Two defined glycoconjugates (GP-10/20 and FR II Phe) purified from Leishmania mexicana subsp. amazonensis were analyzed with respect to their ability to induce cellular responses in immunized and infected mice. Each glycoconjugate was recognized by specific immune cells, as assessed by the proliferative response of lymph node cells of immunized mice. The response to GP-10/20 depended on helper T cells and antigen-presenting cells and was restricted by a major histocompatibility complex class II gene product. A specific anti-GP-10/20 T-cell line was established, and it was able to transfer a delayed-type hypersensitivity (DTH) response to normal mice. Both antigens were also recognized during an ongoing disease, as assessed by DTH response of infected mice. By this response, it was possible to distinguish susceptible from resistant strains of mice. In the course of the disease in resistant mice a correlation between the size of the primary lesion and the DTH response to GP-10/20 was observed. The presence of the glycoproteins on both promastigote and amastigote forms of the parasite, the antigenic similarities between both fractions, and the distribution of the GP-10/20 antigen in other trypanosomatids were studied. The results showed that both antigens were present on promastigotes and amastigotes. GP-10/20 shared no epitopes with FR II Phe, was included as part of the crude preparation leishmanin, and had some cross-reactive determinants with Leishmania donovani and Crithidia deanei.
Cutaneous leishmaniasis is a disease characterized by a single cutaneous lesion that resolves either spontaneously or with the aid of pentavalent antimonial therapy. Healing is accompanied by the development of cellular immunity against antigens of the parasite. In a very few patients, the disease can develop into a diffuse form which is usually fatal. Patients with diffuse cutaneous leishmaniasis are anergic to parasite antigens. The full spectrum of the disease can be reproduced in different inbred strains of mice according to their genetic constitution (7, 19) . When Leishmania major is the etiological agent, helper T cells are required for the resistance of CBA mice, and suppressor cells are associated with the susceptibility of BALB/c mice (13) . A clone of suppressor T cells specific for parasite antigens and able to increase the lesion size in infected BALB/c mice has been described previously (12) . All of these observations support the notion that immunological phenomena are critical in the pathogenesis of cutaneous leishmaniasis caused by L. major. Much less is known about the immunopathological phenomena involved in cutaneous leishmaniasis and diffuse cutaneous leishmaniasis induced by Leishmania mexicana subsp. amazonensis. It has been shown that susceptible (BALB/c) mice, unlike resistant strains, are unable to evince a delayedtype hypersensitivity (DTH) response to parasite antigens (1, 2) . The DTH response is believed to be related to the ability to resist infection.
Extensive experimental work is being done lately on the characterization of biologically active molecules extracted from different microorganisms. These molecules are potentially useful for studies of the taxonomy (20, 21) of parasites, as well as for differential diagnosis (24) prophylaxis, and for a better understanding of phenomena underlying hostparasite interactions (17) . * Corresponding author.
In this study, we examined the immune responses of susceptible and resistant strains of mice to two purified glycoconjugates extracted from L. mexicana subsp. amazonensis. Immunized and infected mice exhibited a specific response to the purified antigens. Susceptible and resistant strains differed in the intensity of their DTH reactions to the purified glycoconjugates. Antigenic determinants of the glycoconjugates were present in both differentiation forms of the parasite. The importance of studying such purified antigens for a better understanding of the pathogenesis of leishmaniasis is discussed.
MATERIALS AND METHODS
Animals. Male and female mice of strains C57BL/10 (B10), C57BL/10.A (B1O.A), and BALB/c (4 to 20 weeks old, raised in our own facilities) were used throughout the studies.
Parasites The lesion was aseptically dissected out, washed in sterile HBSS, finely teased, and ground in a glass homogenizer containing cold HBSS. The suspension was then centrifuged at 200 x g to remove large debris, and the amastigotes from the supernatant were washed at least twice in cold HBSS.
The parasites were counted in a Neubauer chamber and adjusted to the desired concentration.
Extraction and purification of L. mexicana subsp. amazonensis antigens. Frozen cells were rapidly thawed and extracted as described by Mendonca-Previato et al. (18) . The aqueous extract (AE) was fractionated by gel filtration chromatography on a Bio-Gel P-10 column (120 by 2 cm). The material that emerged in the void volume was designated GP-10/20. The remaining cellular pellet was extracted with a hot phenol-water solution, and the aqueous layer thus obtained was dialyzed, lyophilized, and purified by gel filtration chromatography on a Bio-Gel P-100 column (100 by 1 cm). The void volume was designated FR II Phe. Leishmanin was prepared from promastigotes of L. mexicana subsp. amazonensis that were grown and harvested as described above. The cells were washed, frozen, and thawed 10 times, solubilized in 8 M urea, dialyzed overnight against a large volume of phosphate-buffered saline, and centrifuged at 33,000 x g for 1 h. Difco Laboratories, Detroit, Mich.), and 50,ul of the emulsion was injected into each hind footpad.
Infection. Amastigotes of L. mexicana subsp. amazonensis were obtained as described above, and the concentration was adjusted to 1 x 106 to 2 x 106 parasites per ml in HBSS. Mice of each strain were inoculated subcutaneously with 0.1 ml in the left hind footpad. Infection was quantified by measuring the increase in thickness of the footpad with an engineering caliper. The size of the lesion during the course of the infection was calculated as the difference in thickness between the pads in infected and noninfected mice.
Measurement of DTH responses. Mice that had been infected in the left footpad were injected in the right footpad with 50 pAl of purified antigen or with leishmanin. The degree of swelling was expressed as the difference in millimeters between the thickness of the footpad before injection and the thickness measured after 6, 24, and 48 h, or as the percentage of swelling according to the following relationship: percent swelling = (thickness after injection -thickness before injection)/thickness before injection. footpad of normal syngenic mice, and the DTH response was measured as described above.
T-cell proliferation assay. Culture medium consisted of RPMI 1640 medium supplemented with gentamicin (10 pug/ml; Schering, Rio de Janeiro), L-glutamine (2 mM; Sigma), 2-mercaptoethanol (5 x 10-5 M; Eastman Kodak Co., Rochester, N.Y.), and 5% fetal calf serum (Microbiol6gica, Rio de Janeiro) or 5% heat-inactivated normal human serum. Whole LNC were cultivated at 37°C for 3 days in a humid environment containing 5% CO2. Cells were cultivated at a density of 4 x 105 per well in 96-well round-bottom microtiter plates (Linbro) containing the appropriate antigen concentration. In some experiments a monoclonal anti-I region-associated antigen (Ia) antibody (I-Ek/Ck, Litton Bionetics, Charleston, S.C.) was used to block T-cell proliferation. A monoclonal antibody against the helper T-cell antigen L3T4 (a kind gift of Ethan M. Shevach, National Institute of Allergy and Infectious Diseases) was also employed. This antibody (monoclonal antibody [MAb] a L3T4) was obtained as described previously (28) Fig. 1A and B) . This fraction contained 50% protein and 15% carbohydrate on a dry weight basis. FR II Phe showed a large band of Mr -14,000, strongly stained with the periodic acid-Schiff reagent (Fig. 1C) 2) . The lack of proliferative response to the purified glycoconjugates in BALI3/c mice immunized with PPD or with the parasite growth medium (data not shown) shows that the response is not due to a nonspecific mitogenic effect of the purified glycoconjugates.
Proliferative response to GP-10/20 is helper T-cell dependent. To define the role of helper T cells, MAb a L3T4 (GK1.5) was used. It has been reported that the addition of a. L3T4 in culture can inhibit all functions of helper T-cell clones stimulated with soluble antigens (28) . A 10% concentration of a L3T4 completely suppressed the proliferative response of LNC to GP-10/20 (Fig. 3B) . The suppression was reduced by diluting the monoclonal antibody. The ot L3T4 had no effect on the B-cell proliferative response to lipopolysaccharide B of Escherichia coli (LPS) (Fig. 3A) , showing that the suppressive effect in the antigen-specific T-cell proliferation is not due to a nonspecific toxicity of the reagent.
Helper T-cell recognition of GP-10/20 is dependent on APC and involves gene products of the major histocompatibility complex I region. LNL were purified as described above. Spleen cells from a nonimmune mice were treated with mitomycin C to use as APC. Immune LNL were cultured for 3 days with either the antigen, APC, or both. Recognition of the antigen required the presence of APC (Table 2 ). Since antigen recognition by helper T cells is generally considered to be restricted by gene products of the major histocompatibility complex (MHC) I region (Ia antigens), we used an anti-Iak MAb in an attempt to block the specific proliferative response to GP-10/20. Table 3 shows that the MAb induces a partial (42%) blockade of LNC proliferation but has no effect on the B-lymphocyte blastogenic response to LPS. These results are consistent with the hypothesis that some of the helper T cells recognize GP-10/20 in association with the epitope that is blocked specifically by the MAb anti-Iak.
Purified antigens GP-10/20 and FR II Phe are present in amastigotes of L. mexicana subsp. amazonensis. As a means of assessing whether the purified glycoconjugates were present in the intracellular form of the parasite, BALB/c mice were immunized with amastigotes that had been obtained from a lesion of a BALB/c mouse and emulsified in CFA. Proliferative response of LNC to both antigens is shown in Table 4 . These data imply that these glycoconjugates bear nondifferentiation epitopes.
T-cell anti-GP-10/20 are able to transfer a local DTH response to a normal syngenic mouse. To was observed when mice were injected with the anti-GP-10/20 T-cell line in addition to the antigen, but not when injected with the antigen alone. A less marked DTH response was observed when the T-cell line was anti-PPD (Table 5 ). This evidence supports the notion that an anamnestic in vivo response is important in the generation of a DTH reaction.
Leishmanin bears T-cell activating epitopes not present in response of mice immunized with L. donovani Sudan and C. deanei (wild-type strain) was stimulated in a dose-dependent manner by the presence of GP-10/20 in the cultures (Table 6 ). Apparently, this glycoconjugate has antigenic epitopes that are neither species nor genus specific. Infected resistant and susceptible mice respond to GP-10/20 and to FR II Phe. As a means of assessing the recognition of the purified glycoconjugates by immune cells of infected animals, B10.A (resistant) and BALB/c (susceptible) mice were infected with 105 L. mexicana subsp. amazonensis amastigotes in one of the hind footpads. Twelve weeks later the DTH responses to the purified glycoconjugates and to leishmanin, as a positive control, were measured in the infected mice of both strains and in uninfected controls. The purified antigens evoked a DTH response in both strains of mice (Fig. 5) . However, the intensity of the response in the resistant strain was higher than that in the susceptible strain. Figure 6 shows the time course of the size of the primary lesion, which correlates with the number of parasites, and of the DTH response to GP-10/20 in the resistant strain of mice. The high correlation coefficient (0.96) suggests that the intensity of the DTH response is dependent on the antigenic load. Both the difference in DTH intensity in susceptible and resistant mice and the correlation with the size of the lesion observed with the purified antigens already have been described with leishmanin (2).
DISCUSSION
The role of cell-mediated immunity in the fate of the cutaneous lesion in leishmaniasis is at present a debatable issue. DTH reactions have been associated with the acquisition by the host of immune mechanisms effective in the elimination of the parasite and in protection from reinfections (8, 13, 23) . Recently, a cloned T-cell line able to specifically suppress the DTH response to leishmanial antigens was shown to enhance the size of the lesion on susceptible mice (12) . However T-cell lines positive for the L3T4 marker capable of transferring parasite-specific DTH responses and of activating macrophages to destroy leish- mania were shown to exacerbate the lesions when transferred to infected resistant and susceptible mice (27) . Also, protective immunity has been achieved with an immunization schedule that fails to raise a DTH response (9) . Those studies were made with whole organisms or the soluble fractions of crude promastigote extracts (leishmanin) of L. major. Less is known about the murine model of leishmaniasis induced by L. mexicana subsp. amazonensis, although evidence exists of similarities in some of the genetic, immunological, and pathological findings among the different models (1, 19, 20) . The use of whole organisms or crude antigenic extracts raises some considerations. Leishmania spp. undergo changes in expressed proteins during their differentiation process (3, 5, 6) , and amastigote and promastigote forms of leishmania do not share the same antigenic pattern (amount and quality). Even within promastigotes differences in infectivity (22) and in lectin binding (21a) have been described in parasites at different points of their growth curve. Furthermore, no evidence excludes the possibility that different antigens are related to different immune effector mechanisms. A specific epitope has been shown to be related to the suppressor mechanism in lepromatous leprosy (17) .
To circumvent some of the limitations described above, we used purified and well-defined glycoconjugates extracted from L. mexicana subsp. amazonensis as antigens.
The results of this study show that the two glycoconjugates are immunogenic and antigenic not only for infected and immunized mice of different H-2 haplotypes, but for mice with different degrees of susceptibility to the disease (Fig. 2) . BALB/c, B10, and B1O.A mice respond in a lymph node proliferative assay to GP-10/20, and BALB/c mice respond to FR II Phe; BALB/c and B1O.A exhibit a DTH response to both antigens during an ongoing infection (Fig. 5) . Under the conditions used in this study, the intensity of the DTH response is greater in the resistant (B1O.A) than in the susceptible (BALB/c) strain of mice. Interestingly, the DTH response of BALB/c mice to GP-10/20 (P = 0.10 at 24 h; P = 0.20 at 48 h), which is an antigen contained in leishmanin, suggests that the unresponsiveness to the crude extract may be due to quantitative rather than qualitative differences in the immunogenic properties of some of its molecular constituents.
The purified glycoconjugate GP-10/20 is recognized in immunized animals by nylon wool nonadherent cells via APC (Table 2 ) and class II MHC gene products ( Table 3) . The LNC proliferative response was shown to be dependent on L3T4-positive helper T cells (Fig. 3) . The functional characteristic of GP-10/20-specific T cells maintained in vitro was seen by the ability of those cells to transfer DTH response (Table 5) . Our data confirm, for the purified glycoconjugate, the prevailing view on antigen presentation to helper T cells by Ia-bearing accessory cells (15, 25) .
The antigens GP-10/20 and FR II Phe are present in both promastigote and amastigote forms of the parasite ( Table 4 ). It was also observed that L. donovani promastigotes and C. deanei culture forms bear a cross-reactive epitope with GP-10/20 (Table 6) . Many cross-reactive as well as species-and subspecies-specific epitopes recently have been described with the use of antileishmanial MAbs (4, 16) or murine T-cell clones (27) . In a cross-panel analysis employing MAb specific for Leishmania spp., cross-reaction was observed with GP-10/20 and several MAbs specific for Leishmania mexicana (D. McMahon-Pratt, personal communication). The possibility that cross-reactive (public) and species-specific (private) epitopes are part of the same molecule is now being investigated. The antigens described here could turn out to be useful tools for studying the mechanism involved in the generation of the specific suppressor and effector mechanisms underlying susceptibility or resistance to the disease.
